Abstract
Antimicrobial resistance (AMR) is considered one of the most serious global health challenges of the twenty-first century. This article reviews the main molecular mechanisms employed by bacteria to resist antibiotics, the role of horizontal gene transfer and biofilms in the spread of resistance, and the importance of the ESKAPE group of bacteria. It also discusses modern strategies to combat this phenomenon, including molecular surveillance, phage therapy, the development of new antibiotics, and antimicrobial stewardship.
Keywords: Antibiotic Resistance, Horizontal Gene Transfer, Plasmids, Biofilms, ESKAPE, Bacteriophages.
1. Introduction
The discovery of antibiotics in the twentieth century brought about a radical transformation in medicine, significantly reducing mortality rates caused by bacterial infections. However, their excessive and irrational use in human medicine, veterinary medicine, and agriculture has created selective pressure, driving bacteria to develop multiple resistance mechanisms.
A study published in The Lancet in 2022 estimated that bacterial antimicrobial resistance was associated with approximately 4.95 million deaths worldwide in 2019, including around 1.27 million deaths directly attributable to it (Murray et al., 2022). The seriousness of this phenomenon is increasing due to the slowdown in the discovery of new classes of antibiotics.
2. Molecular Mechanisms of Antibiotic Resistance
Bacteria rely on four major mechanisms of antibiotic resistance, and a single bacterial strain may employ several of them simultaneously:
A. Enzymatic Inactivation of Antibiotics:
Bacteria produce enzymes that break down antibiotics or chemically modify them. Examples include beta-lactamase enzymes, such as extended-spectrum beta-lactamases (ESBLs) and carbapenemases, which hydrolyze the beta-lactam ring found in penicillins and cephalosporins.
B. Modification of the Drug Target:
Mutations or modifications may occur at the antibiotic-binding site, reducing the drug’s affinity for its target. An example is the acquisition of the mecA gene by Staphylococcus aureus, which encodes the PBP2a protein responsible for methicillin resistance (MRSA).
C. Efflux Pumps:
These are membrane transport systems that expel antibiotics from bacterial cells before they reach an effective concentration. They play a significant role in multidrug resistance in Pseudomonas aeruginosa.
D. Reduced Permeability:
Bacteria may reduce the number of porin channels or alter their structure in the outer membrane of Gram-negative bacteria, thereby limiting antibiotic entry into the cell.
3. Horizontal Gene Transfer
Antibiotic resistance is not limited to spontaneous mutations. Horizontal gene transfer enables the exchange of resistance genes between different bacterial strains and species through three main mechanisms:
• Conjugation: The transfer of plasmids through direct contact between bacterial cells, representing one of the most important pathways for spreading antibiotic resistance.
• Transformation: The uptake of free DNA from the surrounding environment.
• Transduction: The transfer of genetic material through bacteriophages.
Mobile genetic elements, such as transposons and integrons, also contribute to the accumulation of multiple resistance genes within a single genetic structure. This explains the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacterial strains (Davies & Davies, 2010).
4. Biofilms and Antibiotic Resistance
Bacteria form organized communities within a matrix composed of polysaccharides, proteins, and extracellular DNA, known as biofilms. This structure significantly increases bacterial tolerance to antibiotics through several factors:
• Restricting antibiotic penetration through the biofilm matrix.
• The presence of slow-growing or dormant cells known as persister cells.
• Facilitating gene exchange between neighboring bacterial cells.
Therefore, biofilms are associated with chronic infections that are difficult to treat, particularly those related to catheters and implanted medical devices.
5. ESKAPE Bacteria
The acronym ESKAPE refers to a group of some of the most dangerous causes of healthcare-associated infections. These bacteria include:
• Enterococcus faecium
• Staphylococcus aureus
• Klebsiella pneumoniae
• Acinetobacter baumannii
• Pseudomonas aeruginosa
• Enterobacter spp.
These bacterial species are characterized by their ability to “escape” the effects of antibiotics. Consequently, they have been classified by the World Health Organization among the highest priorities for research and the development of new antibiotics.
6. Strategies to Combat Antimicrobial Resistance
1. Surveillance and Rapid Diagnosis:
Techniques such as polymerase chain reaction (PCR) and whole-genome sequencing (WGS) enable the early detection of resistance genes and the tracking of the spread of epidemic strains, thereby supporting accurate and targeted therapeutic decisions.
2. Antimicrobial Stewardship:
Institutional programs aimed at selecting the appropriate medication, dosage, and duration of treatment while minimizing unnecessary antibiotic use. This is one of the most effective interventions for reducing selective pressure.
3. Phage Therapy:
The use of bacteriophages (viruses that infect bacteria) to target specific bacterial pathogens. This approach has shown promising results in cases of infections resistant to conventional treatments, although further well-designed clinical trials are needed.
4. Development of New Antibiotics and Inhibitors:
This includes modern beta-lactamase inhibitors, antimicrobial peptides, and the exploration of compounds from unconventional sources, such as environmental microbiomes, in addition to the application of artificial intelligence in compound discovery.
5. One Health Approach:
Controlling antimicrobial resistance requires coordination between human health, animal health, and environmental sectors, as resistance genes can spread between these interconnected systems.
7. Conclusion
Antimicrobial resistance represents the result of a complex interaction between bacterial evolution and human practices. It cannot be addressed through a single solution, but rather requires an integrated approach combining molecular understanding of resistance mechanisms, accurate diagnosis, responsible antimicrobial use, therapeutic innovation, and coordinated health policies.
Investment in scientific research and public awareness remains essential to preserving the effectiveness of antibiotics for future generations.
University of Al-Mustaqbal – The First and Leading Private University